Drug Profile
Research programme: vasoactive intestinal peptide antagonists - Bayer
Alternative Names: JV-1-53Latest Information Update: 29 Mar 2010
Price :
$50
*
At a glance
- Originator Bayer
- Class Peptides
- Mechanism of Action Vasoactive intestinal polypeptide antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 29 Mar 2010 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 13 Apr 2004 Preclinical trials in Cancer in USA (unspecified route)